Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

17β-Estradiol boosts allergic reactions and slows thymus aging in mice.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Polymers increased skin permeation and stability of steroid hormones in liposomal formulations.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Estrogen alone can lower testosterone in some transfeminine people.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Skin hormone levels change significantly after menopause.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Progesterone may help trans women with breast development and health, but more research is needed.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.